Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: Can computational intelligence be used to augment clinical assessments?

Arjun P. Athreya; Ravishankar Iyer; Liewei Wang; Richard M. Weinshilboum; William V. Bobo

doi:10.2217/pgs-2019-0119

Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: Can computational intelligence be used to augment clinical assessments?

Arjun P. Athreya, Ravishankar Iyer, Liewei Wang, Richard M. Weinshilboum, William V. Bobo

Research output: Contribution to journal › Review article

Original language	English (US)
Pages (from-to)	983-988
Number of pages	6
Journal	Pharmacogenomics
Volume	20
Issue number	14
DOIs	https://doi.org/10.2217/pgs-2019-0119
State	Published - Jan 1 2019

Keywords

antidepressants
artificial intelligence
clinical response
depression
major depression

ASJC Scopus subject areas

Molecular Medicine
Genetics
Pharmacology

Cite this

Athreya, A. P., Iyer, R., Wang, L., Weinshilboum, R. M., & Bobo, W. V. (2019). Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: Can computational intelligence be used to augment clinical assessments? Pharmacogenomics, 20(14), 983-988. https://doi.org/10.2217/pgs-2019-0119

Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment : Can computational intelligence be used to augment clinical assessments? / Athreya, Arjun P.; Iyer, Ravishankar; Wang, Liewei; Weinshilboum, Richard M.; Bobo, William V.

In: Pharmacogenomics, Vol. 20, No. 14, 01.01.2019, p. 983-988.

Research output: Contribution to journal › Review article

@article{d9fe545af7a7493ebcd5caefa32f7e9c,

title = "Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: Can computational intelligence be used to augment clinical assessments?",

keywords = "antidepressants, artificial intelligence, clinical response, depression, major depression",

author = "Athreya, {Arjun P.} and Ravishankar Iyer and Liewei Wang and Weinshilboum, {Richard M.} and Bobo, {William V.}",

year = "2019",

month = jan

day = "1",

doi = "10.2217/pgs-2019-0119",

language = "English (US)",

volume = "20",

pages = "983--988",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "14",

}

TY - JOUR

T1 - Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment

T2 - Can computational intelligence be used to augment clinical assessments?

AU - Athreya, Arjun P.

AU - Iyer, Ravishankar

AU - Wang, Liewei

AU - Weinshilboum, Richard M.

AU - Bobo, William V.

PY - 2019/1/1

Y1 - 2019/1/1

KW - antidepressants

KW - artificial intelligence

KW - clinical response

KW - depression

KW - major depression

UR - http://www.scopus.com/inward/record.url?scp=85072712741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072712741&partnerID=8YFLogxK

U2 - 10.2217/pgs-2019-0119

DO - 10.2217/pgs-2019-0119

M3 - Review article

C2 - 31559920

AN - SCOPUS:85072712741

VL - 20

SP - 983

EP - 988

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 14

ER -

Access to Document

10.2217/pgs-2019-0119